You are here: All Products  > SciClone Acquires China Rights for PAD Drug from Taiwan Liposome

SciClone Acquires China Rights for PAD Drug from Taiwan Liposome

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.